Shorla Oncology Announces U.S. FDA Approval of Nelarabine Injection for the Treatment of T-cell Leukemia

Media coverage

• Title	Shorla Oncology Announces U.S. FDA Approval of Nelarabine Injection for the Treatment of T-cell Leukemia
  Media name/outlet	HealthcareBusinessToday.com
  Country/Territory	United States
  Date	8/03/23
  URL	https://www.healthcarebusinesstoday.com/shorla-oncology-announces-u-s-fda-approval-of-nelarabine-injection-for-the-treatment-of-t-cell-leukemia/
  Persons	Stephen Hunger